Ankur Drugs & Pharma Ltd.
|BSE: 531683||Sector: Health care|
|NSE: ANKURDRUGS||ISIN Code: INE238D01012|
|BSE 05:30 | 01 Jan||Ankur Drugs & Pharma Ltd|
|NSE 05:30 | 01 Jan||Ankur Drugs & Pharma Ltd|
Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - News Sector
1.47 am | 18 May 2022 | Business Standard
Operating revenue rose 12.7% during the quarter to Rs 485.5 cr; Covid-19 and allied segments added roughly 13.6% to Q4 top line
12.42 pm | 17 May 2022 | Business Standard
Analysts at ICICI Securities expect Aurobindo Pharma's adjusted PAT to de-grow 30.4 per cent year-on-year (YoY) to Rs 557.90 crore in the March 2022 q...
1.05 am | 17 May 2022 | Press Trust of India
Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said ...
3.01 am | 16 May 2022 | Business Standard
The last two years saw limited physical inspections due to travel restrictions during the pandemic
12.04 am | 14 May 2022 | Business Standard
Uncontrolled LDL-c, which poses a major risk of cardiovascular diseases, lacked proper treatment despite patients' lifestyle changes and use of statin...
2.03 am | 12 May 2022 | Business Standard
Speaking to Business Standard, Samina Hamied, executive vice chairperson, Cipla, says one must invest in research and development (R&D) to feed the co...
11.46 pm | 11 May 2022 | Business Standard
The Covid-19 portfolio contributed 5-6 per cent of Cipla's turnover during peak Covid waves, the firm said
12.27 pm | 11 May 2022 | Business Standard
In Q4FY22, Ajanta's earnings before interest, taxes, depreciation, and amortization declined 20 per cent year-on- year to Rs 207 crore.
8.11 am | 11 May 2022 | Business Standard
Stocks to Watch Today: The primary market too is likely to be abuzz with activity with three IPOs namely - Delhivery, Prudent Corporate Advisory Servi...
2.26 am | 11 May 2022 | Business Standard
For the full fiscal, Cipla has posted a 4.7% jump in net profit to Rs 2,517 crore, revenue and Ebitda rose 13.6% and 6.4% respectively
1.22 am | 11 May 2022 | Business Standard
Plant's OAI status is unchanged, hinting at status quo; Sun Pharma says will respond to observations within 15 days
11.10 pm | 10 May 2022 | Business Standard
Stock end at Rs 450, Rs 92 below issue price of Rs 542 a share
10.30 am | 10 May 2022 | Business Standard
The stock listed at Rs 506, a 7% discount when compared with its issue price of Rs 542 per share on the BSE.
11.43 pm | 6 May 2022 | Business Standard
Tech Mahindra and Wipro have tumbled over 30 per cent, while Apollo Hospitals Enterprise and Dr. Reddy's Laboratories have plummeted 22 per cent so fa...
12.29 am | 6 May 2022 | Business Standard
Products in the price control list and growth of the non-power brand portfolio will be key monitorables
9.34 am | 5 May 2022 | Business Standard
The centre integrates two essential functions under the export-oriented undertaking of Pfizer: Pharmaceutical Sciences (PharmSci) and Global Technolog...
11.47 am | 4 May 2022 | Business Standard
Shares of Zomato hit a new low of Rs 64.70, down 7 per cent on the BSE in Wednesday's intra-day trade
7.02 pm | 2 May 2022 | Business Standard
During the quarter, Alembic Pharma's US portfolio strengthened with the acquisition of the balance 40 per cent stake in Aleor Dermaceuticals
11.21 am | 2 May 2022 | Business Standard
Jitesh Devendra, former CEO and Managing Director (MD) of the company will return to Solara as MD, to steer the reset strategy of the Company
12.18 pm | 21 Apr 2022 | Business Standard
At 09:15 AM; around 5.42 million equity shares, representing 3.3 per cent of total equity of Gland Pharma, changed hands on the BSE